Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Ross-Macdonald P"'
Autor:
Braun DA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Hou Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA., Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Ficial M; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Sant' Angelo M; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Forman J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA., Ross-Macdonald P; Bristol-Myers Squibb, Princeton, NJ, USA., Berger AC; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Jegede OA; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Elagina L; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Steinharter J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Sun M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Wind-Rotolo M; Bristol-Myers Squibb, Princeton, NJ, USA., Pignon JC; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Cherniack AD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Lichtenstein L; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Neuberg D; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Catalano P; Harvard Medical School, Boston, MA, USA.; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Freeman GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Sharpe AH; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA., McDermott DF; Harvard Medical School, Boston, MA, USA.; Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Signoretti S; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, USA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. cwu@partners.org.; Harvard Medical School, Boston, MA, USA. cwu@partners.org.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. cwu@partners.org., Shukla SA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. sachet_shukla@dfci.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. sachet_shukla@dfci.harvard.edu.; Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA, USA. sachet_shukla@dfci.harvard.edu., Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. toni_choueiri@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. toni_choueiri@dfci.harvard.edu.
Publikováno v:
Nature medicine [Nat Med] 2020 Jun; Vol. 26 (6), pp. 909-918. Date of Electronic Publication: 2020 May 29.